Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Professor Eileen Treacy

Clinical Professor (Clinical Medicine)
      
Profile Photo

Professor Eileen Treacy

Clinical Professor (Clinical Medicine)

 eptreacy@tcd.ie

 


Prof. Eileen Treacy is Clinical Professor of Medicine of Rare Disorders, Trinity College Dublin, previously Clinical Professor of Inborn Errors of Metabolism (Paediatrics) at Trinity College Dublin (2006-2023). Full Clinical Professor at University College, Dublin since 2016. HSE Clinical Lead for the Irish National Rare Diseases Office (2021-October 2024). Clinical Lead for National Rare Diseases Clinical Programme (2014-2021). Adult Metabolic Consultant at The National Centre for Inherited Metabolic Disorders-Adult Services, Mater Misericordiae University Hospital (January 2020 -January 2023), previously joint appointment as Metabolic Consultant to Childrens University Hospital, Temple St. Dublin, and Mater Misericordiae University Hospital, Dublin, 2001 to 2020. Registered in Clinical Genetics and Paediatrics on the Irish Medical Council Specialist Registry. Graduated in Medicine from Trinity College,Dublin. Trained in Paediatrics, (FRCPC Canada), and then Clinical and Biochemical Genetics (FCCMG programme) at McGill University, Montreal, Canada. Subsequently was awarded a two year Canadian Samuel McLoughlin Travelling Fellowship scholarship with further training in Biochemical Genetics at the Murdoch Institute, Royal Childrens Hospital, Melbourne, Australia, and Necker Enfants Malades Hospital, Paris. Appointed, first as Assistant Professor and then promoted to Associate Professor in Paediatrics and Human Genetics at Montreal Childrens Hospital, McGill University, Montreal, Canada (1994 to 2001). Director of the Charles Scriver Biochemical Genetics Unit at Montreal Childrens Hospital/McGill University from 1995 to 2001. Specific research interests are in the diagnosis and treatment of rare and genetic diseases, and metabolic diseases. Principal Investigator (HSE) for EU4Health JARDIN ERN Integration Grant and Co-Lead for Work Package 6, January 2024 to October 2024. Member of the JARDIN Steering group 2023-October 2024. Orphanet national validator and subsequently country Principal Investigator for Pillar II European Joint Research Programme in Rare Diseases (EJPRD) from 2014 to October 2024. Irish Principal Investigator for EC EU4Health OD4RD2 'Orphacode' direct grant (August 2023- October 2024). Member of Steering Group for International Galactosaemia (GALNET) Consortium.
Project Title
 European Brain Council Research Project: The value of treatment for brain disorders in Europe- Phenylketonuria pathway.
From
Jan 1 2021 (for my participation)
To
June 30th 2021
Summary
Funding Agency
EC-European Brain Council
Project Type
Economic and quality analysis
Person Months
6

L.A Shakerdi, C. Newman Thacker, K. Moore, A. Sheerin, M. Noga, M. E Rubio-Gozalbo, G T. Berry, J. J. O"Byrne, R Saldova and E. P. Treacy., Galactose tolerance in adults with classical galactosaemia. Considering the gaps, Molecular Genetics and Metabolism Reports, 46, (February 2026), 2026, p101298 - 101298, Notes: [doi.org/10.1016/j.ymgmr.2026.101298 PMID: 41798075], Journal Article, PUBLISHED
Cannizzo S, Quoidbach V, Gilroy B, Hagedorn T, Bak A, Dickson SL, Treacy EP, Hermida A, MacDonald A, Venegas E, O'Byrne J, Scarpa M, Van Spronsen F, Lange E, Buckinx T, Monavari A, vom Dahl S, Trieste L, Turchett1 G, The role of digital tools and their implementation within Patient Care Pathways for Rare Brain Disorders: the case of Phenylketonuria, European Journal of Neurology, 33, (4), 2026, Notes: [https://onlinelibrary.wiley.com/doi/10.1111/ene.70575], Journal Article, PUBLISHED
Cannizzo S et al including EP Treacy, The organizational dimension in rare and complex diseases care management: an application of RarERN Path methodology in ataxias, dystonia and phenylketonuria, BMC Health Services research, 25 (1), 2025, Journal Article, PUBLISHED  DOI
Pereira D, Loftus E, Thompson CE, Boyle F, McNulty J, Boruah R, Crushell E, Howard C, Hughes J, Monavari AA, Treacy EP, Beegan A, Jordan N, Rogers Y, Collins A, Brady JJ, Elsammak M, Mayne PD, Knerr I., Clinical and Developmental Outcomes After 50"Years of Newborn Bloodspot Screening for Classical Galactosaemia in the Republic of Ireland., JIMD reports, 66, (3), 2025, pe70022 , Notes: [PMID: 40421404 https://onlinelibrary.wiley.com/doi/10.1002/jmd2.70022], Journal Article, PUBLISHED  DOI
Nerney, Darragh, O"Malley, Emer, Kenny, Caroline, Ward, Alana, Sweeney, Geraldine, McGrath, Vicky, Egan, Laura, Treacy, Eileen, Psychological supports for people living with a rare disease in Ireland: an online survey-based study, Irish Journal of Medical Science (1971 -), 2025, Journal Article, PUBLISHED  DOI
Journal of Inborn Errors of Metabolism and Screening, 12, e2023-0016, (2024), Karolina Stepien, Max Treacy, Roulla Katiri, Eileen P. Treacy, Gregory Pastores, Alison Sheerin, Donal Brosnahan, Ellen Crushell, James J. O"Byrne, Notes: [https://doi.org/10.1590/2326-4594-JIEMS-2023-0016], Journal, PUBLISHED
Karolina M. St"pie", Max Treacy, Roulla Katiri, Eileen P. Treacy, Gregory M. Pastores, Alison Sheerin, Donal Brosnahan, Ellen Crushell, James J. O"Byrne, Long-Term Cardiorespiratory, Endocrine, Ophthalmic, and Functional Outcomes in Adult Patients with Mucopolysaccharidosis Type I (Hurler Syndrome) Post Haematopoietic Stem Cell Transplantation: The Irish Experience, Journal of Inborn Errors of Metabolism and Screening, 12, 2024, Journal Article, PUBLISHED  DOI
Timmons A, Ward AJ, Sweeney G, Nerney D, Harris S, Treacy EP, Improving the viibility of Rare Diseases in General Medical Practice, Irish Medical Journal, 117, (10), 2024, p1042 - 1042, Notes: [PMID: 39764775], Journal Article, PUBLISHED
Timmons A, Ward AJ, Sweeney G, Nerney D, Harris S, Treacy EP, Improving the visibility of Rare Diseases in General Medical Practice, Irish Medical Journal, 117, (10), 2024, p1042-, Journal Article, PUBLISHED
Panis B, Vos N et al including EP Treacy, Brain function in classic galactosemia, a galactosemia network (GalNet) members review, Front Genet, 15, (2024), 2024, p13-, Notes: [doi: 10.3389/fgene.2024.1355962. eCollection 2024.], Journal Article, PUBLISHED  DOI  DOI  DOI  DOI
  

Page 1 of 18
Eileen Treacy, Invited speaker: Presentation of Member State survey and 'Irish' experience. , Workshop on ERN Training and Education., European Commission, DG Sante, Brussels, Belgium, February 17, 2019, DG Sante, European Commission, Invited Talk, PUBLISHED
Treacy EP, National Model of Care for Rare Diseases Ireland, Lenus, 2019, Report, PUBLISHED
Department of Health, National Plan for Rare Diseases 2014-2018, Dublin, 2014, Report, PUBLISHED

  


Epidemiology of Rare Diseases Treatment of Genetic Diseases Inborn Errors of Metabolism Galactosaemia, pathophysiology and novel treatment approaches. Co-Lead of the International GalNet consortium. Currently collaborating with European Galactosaemia colleagues in a number of Galactosaemia research projects.